HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
7.54
+0.14 (1.89%)
Apr 29, 2025, 4:00 PM EDT - Market closed

HCW Biologics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for HCW Biologics.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for HCW Biologics.

Recommendation Trends

Rating Jan '23Feb '23Mar '23Apr '23May '23Jun '23
Strong Buy 332220
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 332220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
EF Hutton
EF Hutton
Strong Buy
Initiates
$360
Strong Buy Initiates $360 +4,674.54% Jun 1, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong Buy Reiterates $360 +4,674.54% Apr 19, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong Buy Reiterates $360 +4,674.54% Mar 30, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong Buy Reiterates $360 +4,674.54% Mar 23, 2023
JonesTrading
JonesTrading
Strong Buy
Initiates
$320
Strong Buy Initiates $320 +4,144.03% Nov 8, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 2.57M
Revenue Next Year
n/a
EPS This Year
-22.44
from -30.96
EPS Next Year
-22.03
from -22.44
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
4.10M-6.72M2.84M2.57M---
Revenue Growth
----57.73%-9.68%---
EPS
-59.70-27.41-16.64-27.83-30.96-22.44-22.03-24.07
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -23.10 -22.68 -24.78
Avg -22.44 -22.03 -24.07
Low -21.56 -21.17 -23.13

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.